2,155 reports of this reaction
4.2% of all CEPHALEXIN reports
#1 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #1 most commonly reported adverse reaction for CEPHALEXIN, manufactured by AMELLA PHARMA, LLC. There are 2,155 FDA adverse event reports linking CEPHALEXIN to CHRONIC KIDNEY DISEASE. This represents approximately 4.2% of all 51,762 adverse event reports for this drug.
Patients taking CEPHALEXIN who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is moderately reported among CEPHALEXIN users, representing a notable but not dominant share of adverse events.
In addition to chronic kidney disease, the following adverse reactions have been reported for CEPHALEXIN:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 2,155 FDA reports for CEPHALEXIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 4.2% of all adverse event reports for CEPHALEXIN, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking CEPHALEXIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.